Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Benowitz

Showing results (71-80 of 291) with videos related to

Pageof 30
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1977
Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanolN L Benowitz, R T Jones
The European Respiratory Journal|April 1, 1996
Individualizing medical treatment for tobacco dependenceD P Sachs, N L Benowitz
The New England Journal of Medicine|July 14, 1994
Establishing a nicotine threshold for addiction. The implications for tobacco regulationN L Benowitz, J E Henningfield
American Journal of Epidemiology|March 1, 1995
Re: "Alcohol, smoking, coffee, and cirrhosis" and "coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan"D S Sharp, N L Benowitz
The Medical Clinics of North America|January 1, 1979
Hypertensive emergenciesC E Becker, N L Benowitz
Emergency Medicine Clinics of North America|August 1, 1989
Toxicologic causes of acute abdominal disordersP D Mueller, N L Benowitz
Journal of the American College of Cardiology|June 1, 1997
Cardiovascular toxicity of nicotine: implications for nicotine replacement therapyN L Benowitz, S G Gourlay
BMJ (Clinical Research Ed.)|April 29, 1995
Cigarettes and addictionJ E Henningfield, N L Benowitz
Clinical Pharmacology and Therapeutics|March 1, 1977
Prolonged delta-9-tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockadesN L Benowitz, R T Jones
Clinical Pharmacology and Therapeutics|November 14, 1997
Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotineS G Gourlay, N L Benowitz
Pageof 30

Showing results (71-80 of 291) with videos related to

Sort By:
Pageof 30
Clinical Pharmacology and Therapeutics|September 1, 1977
Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanolN L Benowitz, R T Jones
The European Respiratory Journal|April 1, 1996
Individualizing medical treatment for tobacco dependenceD P Sachs, N L Benowitz
The New England Journal of Medicine|July 14, 1994
Establishing a nicotine threshold for addiction. The implications for tobacco regulationN L Benowitz, J E Henningfield
American Journal of Epidemiology|March 1, 1995
Re: "Alcohol, smoking, coffee, and cirrhosis" and "coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan"D S Sharp, N L Benowitz
The Medical Clinics of North America|January 1, 1979
Hypertensive emergenciesC E Becker, N L Benowitz
Emergency Medicine Clinics of North America|August 1, 1989
Toxicologic causes of acute abdominal disordersP D Mueller, N L Benowitz
Journal of the American College of Cardiology|June 1, 1997
Cardiovascular toxicity of nicotine: implications for nicotine replacement therapyN L Benowitz, S G Gourlay
BMJ (Clinical Research Ed.)|April 29, 1995
Cigarettes and addictionJ E Henningfield, N L Benowitz
Clinical Pharmacology and Therapeutics|March 1, 1977
Prolonged delta-9-tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockadesN L Benowitz, R T Jones
Clinical Pharmacology and Therapeutics|November 14, 1997
Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotineS G Gourlay, N L Benowitz
Pageof 30